Dr. Sepalika Wasanthalal, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5053 South Congress Ave, Suite 201, Atlantis, FL 33462 Phone: 561-357-9060 Fax: 561-357-9460 |
Dr. Hitesh Kapupara, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5503 S. Congress Ave.,, Suite 103, Atlantis, FL 33462 Phone: 561-965-7228 Fax: 561-965-0120 |
Dr. Freya Jan Silverstein, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5503 S Congress Ave, Suite 103, Atlantis, FL 33462 Phone: 561-965-7228 Fax: 561-965-0120 |
News Archive
In this post in The Hill's "Congress Blog," Chris Collins, vice president and director of public policy for amfAR, The Foundation for AIDS Research, responds to a recently released analysis of adult mortality rates in African countries, which "found that between 2004 and 2008, in those nations where the President's Emergency Plan for AIDS Relief (PEPFAR) was most active, the odds of death were about 20 percent lower than in other countries in the region."
Medgenics, Inc., the developer of Biopump, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that its INFRADURE Biopump has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for the treatment of hepatitis D.
Giving a local anaesthetic during a Caesarean section helps manage pain after the operation and can reduce consumption of painkillers, according to Cochrane Researchers. The researchers recommend local anaesthetics as part of integrated pain management strategies for Caesarean section operations, provided that consideration is given to the cost.
Researchers at the Hebrew University of Jerusalem have achieved a breakthrough in monitoring the toxin-delivery system of highly pathogenic bacteria - an accomplishment that could help pave the way for new drugs that will be capable of neutralizing those germs.
Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.
› Verified 9 days ago